Delivery Order SPE2DX22D0099-SPE2D825FAS8D
- Not listed
- This delivery order, awarded on October 13, 2025, represents a $41,482.50 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC vehicle enables the company to supply a comprehensive range of...
- This delivery order, awarded on August 18, 2025, represents a $11,379.98 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This competitively awarded delivery order, with no set-aside designation, requires performance at...
- This delivery order, awarded on October 20, 2025, represents a $122,911.46 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Medical Supply Chain, a defense-focused federal agency. The order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a...
- This delivery order, awarded on October 13, 2025, represents a $59,436.30 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, designated SPE2DX and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to...
- This delivery order, awarded September 15, 2025, represents a $1,753.24 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain. The order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs globally. The contract was...
- This delivery order, awarded September 15, 2025, represents a $10,447.93 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Medical Supply Chain, a defense-focused federal agency. The contract is a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This delivery order carries no set-aside designation,...
- This delivery order, awarded on September 1, 2025, represents a $26,109.22 firm fixed price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 through December 2026. This underlying IDC serves as a comprehensive...
- This delivery order, awarded on October 20, 2025, to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) represents a $33,203.96 firm fixed-price award under the Defense Logistics Agency's Medical Supply Chain program. The contract is a child order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. This particular...
- This delivery order, awarded on September 29, 2025, represents a $41,482.50 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This delivery order is non-set-aside and was competitively awarded, with a...
- This delivery order, awarded August 25, 2025, represents a $13,677.48 firm fixed price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The award carries no set-aside designation, indicating it was competitively awarded...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D825FAS8DDelivery Order
This delivery order, awarded on September 22, 2025, represents a $15,443.12 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order carries no set-aside designation and was competitively awarded, with performance to occur at the company's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract portfolio with DLA demonstrates consistent capability to fulfill federal medical supply requirements through open competition, with delivery orders typically structured as firm fixed-price arrangements. The ultimate completion date for this delivery order is September 23, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 9/22/25 |